Total Valuation
PureTech Health has a market cap or net worth of €338.45M. The enterprise value is €144.89.
Market Cap€338.45M
Enterprise Value€144.89
Share Statistics
PureTech Health has 24,341,820 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding24,341,820
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PureTech Health’s return on equity (ROE) is -0.35 and return on invested capital (ROIC) is -19.67%.
Return on Equity (ROE)-0.35
Return on Assets (ROA)-0.21
Return on Invested Capital (ROIC)-19.67%
Return on Capital Employed (ROCE)-0.20
Revenue Per Employee51.77K
Profits Per Employee-1.22M
Employee Count90
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of PureTech Health is ―. PureTech Health’s PEG ratio is 0.00015.
PE Ratio―
PS Ratio8.60
PB Ratio0.13
Price to Fair Value0.13
Price to FCF-0.47
Price to Operating Cash Flow-0.49
PEG Ratio0.00015
Income Statement
In the last 12 months, PureTech Health had revenue of 4.66M and earned -109.74M in profits. Earnings per share was -46.00.
Revenue4.66M
Gross Profit4.66M
Operating Income-98.53M
Pretax Income-110.93M
Net Income-109.74M
EBITDA-61.80M
Earnings Per Share (EPS)-46.00
Cash Flow
In the last 12 months, operating cash flow was -84.81M and capital expenditures -5.98K, giving a free cash flow of -84.82M billion.
Operating Cash Flow-84.81M
Free Cash Flow-84.82M
Free Cash Flow per Share-3.48
Dividends & Yields
PureTech Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.76
52-Week Price Change-7.75%
50-Day Moving Average13.84
200-Day Moving Average13.60
Relative Strength Index (RSI)45.08
Average Volume (3m)0.00
Important Dates
PureTech Health upcoming earnings date is Aug 27, 2026, TBA (Confirmed).
Last Earnings DateApr 29, 2026
Next Earnings DateAug 27, 2026
Ex-Dividend Date―
Financial Position
PureTech Health as a current ratio of 6.59, with Debt / Equity ratio of 6.33%
Current Ratio6.59
Quick Ratio6.59
Debt to Market Cap0.22
Net Debt to EBITDA3.79
Interest Coverage Ratio-2.15
Taxes
In the past 12 months, PureTech Health has paid -842.00K in taxes.
Income Tax-842.00K
Effective Tax Rate<0.01
Enterprise Valuation
PureTech Health EV to EBITDA ratio is 3.14, with an EV/FCF ratio of 2.28.
EV to Sales-41.69
EV to EBITDA3.14
EV to Free Cash Flow2.28
EV to Operating Cash Flow2.28
Balance Sheet
PureTech Health has €278.89M in cash and marketable securities with €19.76M in debt, giving a net cash position of €259.14M billion.
Cash & Marketable Securities€278.89M
Total Debt€19.76M
Net Cash€259.14M
Net Cash Per Share€10.65
Tangible Book Value Per Share€126.70
Margins
Gross margin is -471.15%, with operating margin of -2114.72%, and net profit margin of -2355.42%.
Gross Margin-471.15%
Operating Margin-2114.72%
Pretax Margin-2380.92%
Net Profit Margin-2355.42%
EBITDA Margin-1326.49%
EBIT Margin-1398.37%
Analyst Forecast
The average price target for PureTech Health is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―